SEC Tracker
Get the app

111 YI

111 FY 2020: revenue $8.2B; diluted EPS −$2.77

Form
20-F
Filed
Period
Importance
Notable
Document
20-F
Exhibit 4.26
Warrants or notes
Exhibit 4.27
Warrants or notes
Exhibit 4.28
Warrants or notes

Key figures from this report

These are the numbers 111 reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$8.2BNo year-earlier figure tagged20-F income statement, on EDGAR
  2. Diluted EPS−$2.77No year-earlier figure tagged20-F income statement, on EDGAR
  3. Cash and cash equivalents$1.2BNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.20-F balance sheet, on EDGAR
  4. Cash from operations−$116.8MNo year-earlier figure tagged20-F cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when 111 files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 5912 and related industry codes: the same peer list as the financial tables.

  1. AiXin Life International AIXN public float $884K, Jun 30, 2025
  2. TREES Corp (Colorado) CANN
  3. CVS Health CVS public float $86.4B, Jun 30, 2025
  4. Flowerkist Skin Care & Cosmetics FKST
  5. Guardian Pharmacy Services GRDN public float $412M, Jun 30, 2025